Multi-cancer early detection (MCED)
Multi-cancer early detection (MCED) screens asymptomatic, average-risk individuals from a single blood draw for molecular signals shared across dozens of cancer types — a population-screening scenario distinct from companion-therapy diagnostics. The technology base is circulating-DNA, methylation-pattern and protein-signal analysis. Sample-prep and signal-analysis reagents are procured.
Procurement category: reagents & kits. Bioecon selects suppliers and organises supply in this category to the customer's brief. Catalogue-level entry: the specific manufacturer, configuration and specification are determined at the enquiry stage. Price — on request.
| Category slug | reagents-kits |
|---|---|
| Cluster | diagnostics-medtech |
| Article | multi-cancer-early-detection |
| Identifier | bio.con.multi-cancer-early-detection.reagents-kits |
| CPV | 33696500 |
| NAICS | 325413 |
| UNSPSC | 47131800 |
| CHINA CP | A0321 |
Every item is a procurement category, not a named manufacturer's product. Bioecon is a single seller and holds no stock: supplier selection, configuration and specification are settled at enquiry, and the price is by quote.